✦ LIBER ✦

HER2-positive breast cancer: trastuzumab, lapatinib and emerging therapies

✍ Scribed by Roger Y. Tsang; Richard S. Finn

Book ID: 119226202
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 176 KB
Volume: 9
Category: Article
ISSN: 1740-6773
DOI: 10.1016/j.ddstr.2011.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted therapies: Combined lapatinib a

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

✍ Castañeda, Carlos A.; Gomez, Henry L. 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

The emerging role of Lapatinib in HER2-p

The emerging role of Lapatinib in HER2-positive breast cancer

✍ Alice Ulhoa-Cintra; Larisa Greenberg; Charles E. Geyer 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 426 KB

Adjuvant Trastuzumab Therapy for HER2-Po

Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer

✍ Mohammad Jahanzeb 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 148 KB

Adjuvant trastuzumab for HER2-positive b

Adjuvant trastuzumab for HER2-positive breast cancer

✍ James Spicer; Mark Harries; Paul Ellis 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 47 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Continued trastuzumab therapy for patien

Continued trastuzumab therapy for patients with HER2-positive breast cancer

✍ F. Haslbauer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB